Bryan, Garnier & Co's News

Read all the news of the independent investment banking dedicated to Growth

Orange Lights are turning green

FV EUR17.1 BUY Coverage initiated

Published last June Wednesday 29, 2016

bioMérieux: FilmArray growth prospects intact, it is all about value added

BUY, Fair Value EUR122 (+7%))

Published last June Wednesday 22, 2016

Infineon: Underestimated potential (focus released today)

BUY, Fair Value EUR15 (+15%)

Published last June Wednesday 22, 2016

ELIOR: On track with 2020 Ambitions (Focus released today)

BUY-Top Picks, Fair Value EUR23 (+14%)

Published last June Wednesday 22, 2016

Genmab: The saga goes on!

BUY, Fair Value DKK1600 vs. DKK1450 (+46%)

Published last June Tuesday 21, 2016

Voltalia: An acquisition that makes sense, despite being dilutive on margin

BUY, Fair Value EUR13 (+46%)

Published last June Tuesday 21, 2016

Roche: APHINITY – it is worth taking the residual risk

BUY, Fair Value CHF293 (+19%)

Published last June Tuesday 21, 2016

AXA: At first sight the 2020 plan looks solid

BUY-Top Picks, Fair Value EUR29 (+41%)

Published last June Tuesday 21, 2016

Dassault Systèmes: Feedback from Capital Markets Day: highlighting the value-based approach

SELL, Fair Value EUR63 vs. EUR62 (-6%)

Published last June Monday 13, 2016
Latest news
See all the news

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities